Pharmaceuticals are useful tools for mechanism of action studies in many ways. Besides being enzyme inhibitors, receptor agonists or antagonists, channel blockers, neurotransmitters themselves, they are used to compare and define other emerging compounds for their prospective applications.
| Structure | Details |
|---|---|
|
|
Product Name: Tramadol hydrochloride Order number: 100970 CAS: 36282-47-0 Purity: >=95% Appearance: solid MF: C16H26ClNO2 MW: 299.839 MP: 180-181 (M.I.) oC Description: Tramadol inhibits the reuptake of norepinephrine and serotonin, and also weakly binds to mu-opioid receptors, blocking pain signals to the brain. |
|
|
Product Name: Ceftriaxone Order number: 100972 CAS: 78384-59-5 Purity: >=95% Appearance: solid MF: C18H18N8O7S3 MW: 554.571 MP: >155 (M.I.) oC Description: This compound blocks bacteria from building their cell walls. |
|
|
Product Name: Testosterone propionate Order number: 100974 CAS: 57-85-2 Purity: >=95% Appearance: solid MF: C22H32O3 MW: 344.495 MP: 118-122 (M.I.) oC Description: This compound binds to androgen receptor (AR), causing the interaction on chromosomal DNA to perturb transcription of androgen-responsive genes. |
|
|
Product Name: Hydroxy progesterone caproate Order number: 100975 CAS: 630-56-8 Purity: >=95% Appearance: solid MF: C27H40O4 MW: 428.613 MP: 119-121 (M.I.) oC Description: This substance is a selective agonist of the progesterone receptor (PR) with minimal or no other hormonal activity. |
|
|
Product Name: Testosterone enanthate Order number: 100977 CAS: 315-37-7 Purity: >=95% Appearance: solid MF: C26H40O3 MW: 400.603 MP: 36-37 (M.I.) oC Description: The mechanism of action involves activation of the androgen receptor (directly or as DHT) and conversion to estradiol and activation of certain estrogen receptors. |
|
|
Product Name: Cefadroxil Order number: 100978 CAS: 66592-87-8 Purity: >=95% Appearance: solid MF: C16H19N3O6S MW: 381.403 MP: 197 (M.I.) oC Description: This substance inactivates one or more penicillin-binding proteins and inhibits cross-linking of the peptidoglycan structure at the later stages of bacterial cell wall synthesis. |